Erlotinib Prevent Disease Recurrence in Early Stage EGFR Positive NSCLC Patients?

http://cancerGRACE.org/... Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-small cell lung cancer patients and whether or not Tarc... Author: cancergrace Added: 05/20/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts